Chronic exposure to trastuzumab increases the IC50 values for both the HCC1954 and SKBR3 cell lines, confirming the development of resistance and mimicking a 2D cell culture model of HER2-positive breast cancer patients. Here, ERBB2 is linked to breast carcinoma.